These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9168247)

  • 1. Disruption of brain cell ion homeostasis in Alzheimer's disease by oxy radicals, and signaling pathways that protect therefrom.
    Mattson MP; Mark RJ; Furukawa K; Bruce AJ
    Chem Res Toxicol; 1997 May; 10(5):507-17. PubMed ID: 9168247
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.
    Smith IF; Hitt B; Green KN; Oddo S; LaFerla FM
    J Neurochem; 2005 Sep; 94(6):1711-8. PubMed ID: 16156741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tipping the apoptotic balance in Alzheimer's disease: the abortosis concept.
    Raina AK; Zhu X; Shimohama S; Perry G; Smith MA
    Cell Biochem Biophys; 2003; 39(3):249-55. PubMed ID: 14716079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early brain response to low-dose radiation exposure involves molecular networks and pathways associated with cognitive functions, advanced aging and Alzheimer's disease.
    Lowe XR; Bhattacharya S; Marchetti F; Wyrobek AJ
    Radiat Res; 2009 Jan; 171(1):53-65. PubMed ID: 19138050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
    Harris CD; Ermak G; Davies KJ
    FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.
    Blain JF; Poirier J
    Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of NADPH oxidase in Alzheimer's disease brains.
    Shimohama S; Tanino H; Kawakami N; Okamura N; Kodama H; Yamaguchi T; Hayakawa T; Nunomura A; Chiba S; Perry G; Smith MA; Fujimoto S
    Biochem Biophys Res Commun; 2000 Jun; 273(1):5-9. PubMed ID: 10873554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol modulates amyloid beta-peptide's membrane interactions.
    Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High carbohydrate diets and Alzheimer's disease.
    Henderson ST
    Med Hypotheses; 2004; 62(5):689-700. PubMed ID: 15082091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RB1CC1 insufficiency causes neuronal atrophy through mTOR signaling alteration and involved in the pathology of Alzheimer's diseases.
    Chano T; Okabe H; Hulette CM
    Brain Res; 2007 Sep; 1168():97-105. PubMed ID: 17706618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
    Drago D; Cavaliere A; Mascetra N; Ciavardelli D; di Ilio C; Zatta P; Sensi SL
    Rejuvenation Res; 2008 Oct; 11(5):861-71. PubMed ID: 18788899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal anion exchange proteins in Alzheimer's disease pathology.
    Bosman GJ; Renkawek K; Van Workum FP; Bartholomeus IG; Marini S; De Grip WJ
    J Neural Transm Suppl; 1998; 54():248-57. PubMed ID: 9850933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha2beta1 and alphaVbeta1 integrin signaling pathways mediate amyloid-beta-induced neurotoxicity.
    Wright S; Malinin NL; Powell KA; Yednock T; Rydel RE; Griswold-Prenner I
    Neurobiol Aging; 2007 Feb; 28(2):226-37. PubMed ID: 16448724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).
    Onyango IG; Tuttle JB; Bennett JP
    Mol Cell Neurosci; 2005 Jun; 29(2):333-43. PubMed ID: 15911356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
    Wyss-Coray T
    J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mitochondrial dysfunction in Alzheimer's disease.
    Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.